BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18332314)

  • 1. Effect of human tears on acanthamoeba-induced cytopathic effect.
    Cao Z; Saravanan C; Goldstein MH; Wu HK; Pasricha G; Sharma S; Panjwani N
    Arch Ophthalmol; 2008 Mar; 126(3):348-52. PubMed ID: 18332314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milk components inhibit Acanthamoeba-induced cytopathic effect.
    Saravanan C; Cao Z; Kumar J; Qiu J; Plaut AG; Newburg DS; Panjwani N
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1010-5. PubMed ID: 18326724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of acanthamoeba keratitis.
    Panjwani N
    Ocul Surf; 2010 Apr; 8(2):70-9. PubMed ID: 20427010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein.
    Garate M; Marchant J; Cubillos I; Cao Z; Khan NA; Panjwani N
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1056-62. PubMed ID: 16505041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection.
    Leher H; Kinoshita K; Alizadeh H; Zaragoza FL; He Y; Niederkorn J
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2337-43. PubMed ID: 9804142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mucosal IgA in the resistance to Acanthamoeba keratitis.
    Leher HF; Alizadeh H; Taylor WM; Shea AS; Silvany RS; Van Klink F; Jager MJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2666-73. PubMed ID: 9856776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human tear fluid in Acanthamoeba interactions with the human corneal epithelial cells.
    Alsam S; Jeong SR; Dudley R; Khan NA
    Int J Med Microbiol; 2008 Apr; 298(3-4):329-36. PubMed ID: 17931971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization and functional studies of Acanthamoeba mannose-binding protein.
    Garate M; Cubillos I; Marchant J; Panjwani N
    Infect Immun; 2005 Sep; 73(9):5775-81. PubMed ID: 16113295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis.
    Clarke DW; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4917-25. PubMed ID: 17065507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal IgA antibodies protect against Acanthamoeba keratitis.
    Leher H; Zaragoza F; Taherzadeh S; Alizadeh H; Niederkorn JY
    Exp Eye Res; 1999 Jul; 69(1):75-84. PubMed ID: 10375451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acanthamoeba can be differentiated by the polymerase chain reaction and simple plating assays.
    Khan NA; Jarroll EL; Paget TA
    Curr Microbiol; 2001 Sep; 43(3):204-8. PubMed ID: 11400071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Value of Cellulose Synthesis Inhibitors Combined With PHMB in the Treatment of Acanthamoeba Keratitis.
    Moon EK; Hong Y; Chung DI; Goo YK; Kong HH
    Cornea; 2015 Dec; 34(12):1593-8. PubMed ID: 26426333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acanthamoeba pathogenicity for corneal cells.
    Kinnear FB
    J Infect; 2004 Nov; 49(4):310-6. PubMed ID: 15474629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acanthamoeba castellanii: morphological analysis of the interaction with human cornea.
    Omaña-Molina M; González-Robles A; Salazar-Villatoro LI; Cristóbal-Ramos AR; González-Lázaro M; Salinas-Moreno E; Méndez-Cruz R; Sánchez-Cornejo M; De la Torre-González E; Martínez-Palomo A
    Exp Parasitol; 2010 Sep; 126(1):73-8. PubMed ID: 20146924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic humoral immune response during acute and chronic Acanthamoeba keratitis in rabbits.
    Said NA; Shoeir AT; Panjwani N; Garate M; Cao Z
    Curr Eye Res; 2004 Dec; 29(6):429-39. PubMed ID: 15764087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis.
    Alizadeh H; Apte S; El-Agha MS; Li L; Hurt M; Howard K; Cavanagh HD; McCulley JP; Niederkorn JY
    Cornea; 2001 Aug; 20(6):622-7. PubMed ID: 11473164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellanii [corrected].
    Niederkorn JY; Ubelaker JE; McCulley JP; Stewart GL; Meyer DR; Mellon JA; Silvany RE; He YG; Pidherney M; Martin JH
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):104-12. PubMed ID: 1730531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba.
    Cao Z; Jefferson DM; Panjwani N
    J Biol Chem; 1998 Jun; 273(25):15838-45. PubMed ID: 9624184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells.
    Hurt M; Niederkorn J; Alizadeh H
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3424-31. PubMed ID: 12882791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of Acanthamoeba castellanii cytopathic effect.
    Taylor WM; Pidherney MS; Alizadeh H; Niederkorn JY
    J Parasitol; 1995 Aug; 81(4):603-9. PubMed ID: 7623204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.